nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—Renal tubular necrosis—Tacrolimus—atopic dermatitis	0.0266	0.0294	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Desonide—atopic dermatitis	0.0247	0.0273	CcSEcCtD
Phenylpropanolamine—Irritability—Desonide—atopic dermatitis	0.0171	0.0189	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—IL2—atopic dermatitis	0.0159	0.748	CrCbGaD
Phenylpropanolamine—Euphoric mood—Diphenhydramine—atopic dermatitis	0.0155	0.0172	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Dimenhydrinate—atopic dermatitis	0.0155	0.0172	CcSEcCtD
Phenylpropanolamine—Pulmonary function test decreased—Tacrolimus—atopic dermatitis	0.0126	0.0139	CcSEcCtD
Phenylpropanolamine—Respiratory depression—Tacrolimus—atopic dermatitis	0.0126	0.0139	CcSEcCtD
Phenylpropanolamine—Irritability—Dimenhydrinate—atopic dermatitis	0.0125	0.0138	CcSEcCtD
Phenylpropanolamine—Irritability—Diphenhydramine—atopic dermatitis	0.0125	0.0138	CcSEcCtD
Phenylpropanolamine—Urinary retention—Dimenhydrinate—atopic dermatitis	0.0125	0.0138	CcSEcCtD
Phenylpropanolamine—Urinary retention—Diphenhydramine—atopic dermatitis	0.0125	0.0138	CcSEcCtD
Phenylpropanolamine—Liver injury—Tacrolimus—atopic dermatitis	0.0113	0.0125	CcSEcCtD
Phenylpropanolamine—Drowsiness—Diphenhydramine—atopic dermatitis	0.0101	0.0112	CcSEcCtD
Phenylpropanolamine—Drowsiness—Dimenhydrinate—atopic dermatitis	0.0101	0.0112	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Tacrolimus—atopic dermatitis	0.00968	0.0107	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Tacrolimus—atopic dermatitis	0.00951	0.0105	CcSEcCtD
Phenylpropanolamine—Flushing—Pimecrolimus—atopic dermatitis	0.00815	0.009	CcSEcCtD
Phenylpropanolamine—Drowsiness—Loratadine—atopic dermatitis	0.00779	0.0086	CcSEcCtD
Phenylpropanolamine—Tension—Dimenhydrinate—atopic dermatitis	0.00775	0.00856	CcSEcCtD
Phenylpropanolamine—Tension—Diphenhydramine—atopic dermatitis	0.00775	0.00856	CcSEcCtD
Phenylpropanolamine—Nervousness—Diphenhydramine—atopic dermatitis	0.00767	0.00848	CcSEcCtD
Phenylpropanolamine—Nervousness—Dimenhydrinate—atopic dermatitis	0.00767	0.00848	CcSEcCtD
Phenylpropanolamine—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00745	0.00823	CcSEcCtD
Phenylpropanolamine—Vision blurred—Diphenhydramine—atopic dermatitis	0.00745	0.00823	CcSEcCtD
Phenylpropanolamine—Tremor—Diphenhydramine—atopic dermatitis	0.0074	0.00818	CcSEcCtD
Phenylpropanolamine—Tremor—Dimenhydrinate—atopic dermatitis	0.0074	0.00818	CcSEcCtD
Phenylpropanolamine—Agitation—Dimenhydrinate—atopic dermatitis	0.00726	0.00802	CcSEcCtD
Phenylpropanolamine—Agitation—Diphenhydramine—atopic dermatitis	0.00726	0.00802	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Tacrolimus—atopic dermatitis	0.00674	0.00745	CcSEcCtD
Phenylpropanolamine—Urinary retention—Tacrolimus—atopic dermatitis	0.00656	0.00725	CcSEcCtD
Phenylpropanolamine—Confusional state—Dimenhydrinate—atopic dermatitis	0.0065	0.00718	CcSEcCtD
Phenylpropanolamine—Confusional state—Diphenhydramine—atopic dermatitis	0.0065	0.00718	CcSEcCtD
Phenylpropanolamine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00629	0.00695	CcSEcCtD
Phenylpropanolamine—Tachycardia—Diphenhydramine—atopic dermatitis	0.00629	0.00695	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Loratadine—atopic dermatitis	0.00625	0.0069	CcSEcCtD
Phenylpropanolamine—Hypotension—Dimenhydrinate—atopic dermatitis	0.00603	0.00666	CcSEcCtD
Phenylpropanolamine—Hypotension—Diphenhydramine—atopic dermatitis	0.00603	0.00666	CcSEcCtD
Phenylpropanolamine—Tension—Loratadine—atopic dermatitis	0.00597	0.0066	CcSEcCtD
Phenylpropanolamine—Nervousness—Loratadine—atopic dermatitis	0.00591	0.00653	CcSEcCtD
Phenylpropanolamine—Insomnia—Dimenhydrinate—atopic dermatitis	0.00583	0.00644	CcSEcCtD
Phenylpropanolamine—Insomnia—Diphenhydramine—atopic dermatitis	0.00583	0.00644	CcSEcCtD
Phenylpropanolamine—Somnolence—Dimenhydrinate—atopic dermatitis	0.00573	0.00633	CcSEcCtD
Phenylpropanolamine—Somnolence—Diphenhydramine—atopic dermatitis	0.00573	0.00633	CcSEcCtD
Phenylpropanolamine—Agitation—Loratadine—atopic dermatitis	0.00559	0.00618	CcSEcCtD
Phenylpropanolamine—Rash—Desonide—atopic dermatitis	0.00557	0.00615	CcSEcCtD
Phenylpropanolamine—Dermatitis—Desonide—atopic dermatitis	0.00556	0.00614	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00556	0.00614	CcSEcCtD
Phenylpropanolamine—Constipation—Dimenhydrinate—atopic dermatitis	0.00551	0.00609	CcSEcCtD
Phenylpropanolamine—Constipation—Diphenhydramine—atopic dermatitis	0.00551	0.00609	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—TNF—atopic dermatitis	0.00535	0.252	CrCbGaD
Phenylpropanolamine—Constipation—Pimecrolimus—atopic dermatitis	0.00533	0.00589	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00531	0.00587	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00531	0.00587	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00527	0.00582	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisolone—atopic dermatitis	0.00522	0.00576	CcSEcCtD
Phenylpropanolamine—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00515	0.00569	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Hydrocortisone—atopic dermatitis	0.0051	0.00563	CcSEcCtD
Phenylpropanolamine—Tachycardia—Loratadine—atopic dermatitis	0.00485	0.00535	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Triamcinolone—atopic dermatitis	0.0048	0.0053	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Methylprednisolone—atopic dermatitis	0.00479	0.00529	CcSEcCtD
Phenylpropanolamine—Hallucination—Tacrolimus—atopic dermatitis	0.00475	0.00525	CcSEcCtD
Phenylpropanolamine—Dizziness—Fluocinonide—atopic dermatitis	0.00473	0.00522	CcSEcCtD
Phenylpropanolamine—Hypotension—Loratadine—atopic dermatitis	0.00464	0.00513	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.00459	0.00507	CcSEcCtD
Phenylpropanolamine—Rash—Fluocinonide—atopic dermatitis	0.00451	0.00498	CcSEcCtD
Phenylpropanolamine—Dermatitis—Fluocinonide—atopic dermatitis	0.00451	0.00498	CcSEcCtD
Phenylpropanolamine—Insomnia—Loratadine—atopic dermatitis	0.00449	0.00496	CcSEcCtD
Phenylpropanolamine—Flushing—Tacrolimus—atopic dermatitis	0.00443	0.0049	CcSEcCtD
Phenylpropanolamine—Somnolence—Loratadine—atopic dermatitis	0.00442	0.00488	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Betamethasone—atopic dermatitis	0.00435	0.00481	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Dexamethasone—atopic dermatitis	0.00435	0.00481	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Tacrolimus—atopic dermatitis	0.00427	0.00471	CcSEcCtD
Phenylpropanolamine—Dizziness—Dimenhydrinate—atopic dermatitis	0.00426	0.00471	CcSEcCtD
Phenylpropanolamine—Dizziness—Diphenhydramine—atopic dermatitis	0.00426	0.00471	CcSEcCtD
Phenylpropanolamine—Constipation—Loratadine—atopic dermatitis	0.00425	0.00469	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Hydrocortisone—atopic dermatitis	0.00421	0.00464	CcSEcCtD
Phenylpropanolamine—Irritability—Hydrocortisone—atopic dermatitis	0.00411	0.00454	CcSEcCtD
Phenylpropanolamine—Vomiting—Diphenhydramine—atopic dermatitis	0.0041	0.00453	CcSEcCtD
Phenylpropanolamine—Vomiting—Dimenhydrinate—atopic dermatitis	0.0041	0.00453	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Loratadine—atopic dermatitis	0.00409	0.00452	CcSEcCtD
Phenylpropanolamine—Tension—Tacrolimus—atopic dermatitis	0.00408	0.00451	CcSEcCtD
Phenylpropanolamine—Rash—Dimenhydrinate—atopic dermatitis	0.00407	0.00449	CcSEcCtD
Phenylpropanolamine—Rash—Diphenhydramine—atopic dermatitis	0.00407	0.00449	CcSEcCtD
Phenylpropanolamine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00406	0.00449	CcSEcCtD
Phenylpropanolamine—Dermatitis—Diphenhydramine—atopic dermatitis	0.00406	0.00449	CcSEcCtD
Phenylpropanolamine—Nervousness—Tacrolimus—atopic dermatitis	0.00404	0.00446	CcSEcCtD
Phenylpropanolamine—Vomiting—Pimecrolimus—atopic dermatitis	0.00396	0.00438	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Methylprednisolone—atopic dermatitis	0.00395	0.00436	CcSEcCtD
Phenylpropanolamine—Rash—Pimecrolimus—atopic dermatitis	0.00393	0.00434	CcSEcCtD
Phenylpropanolamine—Dermatitis—Pimecrolimus—atopic dermatitis	0.00393	0.00434	CcSEcCtD
Phenylpropanolamine—Vision blurred—Tacrolimus—atopic dermatitis	0.00392	0.00433	CcSEcCtD
Phenylpropanolamine—Tremor—Tacrolimus—atopic dermatitis	0.00389	0.0043	CcSEcCtD
Phenylpropanolamine—Irritability—Methylprednisolone—atopic dermatitis	0.00386	0.00426	CcSEcCtD
Phenylpropanolamine—Nausea—Diphenhydramine—atopic dermatitis	0.00383	0.00423	CcSEcCtD
Phenylpropanolamine—Nausea—Dimenhydrinate—atopic dermatitis	0.00383	0.00423	CcSEcCtD
Phenylpropanolamine—Agitation—Tacrolimus—atopic dermatitis	0.00382	0.00422	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Mometasone—atopic dermatitis	0.0038	0.0042	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisone—atopic dermatitis	0.00379	0.00419	CcSEcCtD
Phenylpropanolamine—Nausea—Pimecrolimus—atopic dermatitis	0.0037	0.00409	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Betamethasone—atopic dermatitis	0.00359	0.00397	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Dexamethasone—atopic dermatitis	0.00359	0.00397	CcSEcCtD
Phenylpropanolamine—Anxiety—Tacrolimus—atopic dermatitis	0.00353	0.0039	CcSEcCtD
Phenylpropanolamine—Irritability—Betamethasone—atopic dermatitis	0.00351	0.00388	CcSEcCtD
Phenylpropanolamine—Irritability—Dexamethasone—atopic dermatitis	0.00351	0.00388	CcSEcCtD
Phenylpropanolamine—Confusional state—Tacrolimus—atopic dermatitis	0.00342	0.00378	CcSEcCtD
Phenylpropanolamine—Tachycardia—Tacrolimus—atopic dermatitis	0.00331	0.00366	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00329	0.00363	CcSEcCtD
Phenylpropanolamine—Dizziness—Loratadine—atopic dermatitis	0.00328	0.00363	CcSEcCtD
Phenylpropanolamine—Hypotension—Tacrolimus—atopic dermatitis	0.00317	0.0035	CcSEcCtD
Phenylpropanolamine—Vomiting—Loratadine—atopic dermatitis	0.00316	0.00349	CcSEcCtD
Phenylpropanolamine—Rash—Loratadine—atopic dermatitis	0.00313	0.00346	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Prednisone—atopic dermatitis	0.00313	0.00346	CcSEcCtD
Phenylpropanolamine—Dermatitis—Loratadine—atopic dermatitis	0.00313	0.00346	CcSEcCtD
Phenylpropanolamine—Insomnia—Tacrolimus—atopic dermatitis	0.00307	0.00339	CcSEcCtD
Phenylpropanolamine—Irritability—Prednisone—atopic dermatitis	0.00306	0.00338	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Tacrolimus—atopic dermatitis	0.00302	0.00334	CcSEcCtD
Phenylpropanolamine—Somnolence—Tacrolimus—atopic dermatitis	0.00302	0.00333	CcSEcCtD
Phenylpropanolamine—Hallucination—Hydrocortisone—atopic dermatitis	0.00296	0.00327	CcSEcCtD
Phenylpropanolamine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00295	0.00326	CcSEcCtD
Phenylpropanolamine—Nausea—Loratadine—atopic dermatitis	0.00295	0.00326	CcSEcCtD
Phenylpropanolamine—Constipation—Tacrolimus—atopic dermatitis	0.0029	0.0032	CcSEcCtD
Phenylpropanolamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00284	0.00313	CcSEcCtD
Phenylpropanolamine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00281	0.00311	CcSEcCtD
Phenylpropanolamine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00281	0.00311	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.0028	0.00309	CcSEcCtD
Phenylpropanolamine—Hallucination—Methylprednisolone—atopic dermatitis	0.00278	0.00308	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisolone—atopic dermatitis	0.00272	0.00301	CcSEcCtD
Phenylpropanolamine—Vomiting—Mometasone—atopic dermatitis	0.00271	0.00299	CcSEcCtD
Phenylpropanolamine—Rash—Mometasone—atopic dermatitis	0.00269	0.00297	CcSEcCtD
Phenylpropanolamine—Dermatitis—Mometasone—atopic dermatitis	0.00268	0.00297	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00266	0.00294	CcSEcCtD
Phenylpropanolamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00265	0.00293	CcSEcCtD
Phenylpropanolamine—Hallucination—Dexamethasone—atopic dermatitis	0.00253	0.0028	CcSEcCtD
Phenylpropanolamine—Hallucination—Betamethasone—atopic dermatitis	0.00253	0.0028	CcSEcCtD
Phenylpropanolamine—Nausea—Mometasone—atopic dermatitis	0.00253	0.0028	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Triamcinolone—atopic dermatitis	0.00251	0.00277	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisolone—atopic dermatitis	0.0025	0.00276	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.0025	0.00276	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.0025	0.00276	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Betamethasone—atopic dermatitis	0.00227	0.00251	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Dexamethasone—atopic dermatitis	0.00227	0.00251	CcSEcCtD
Phenylpropanolamine—Dizziness—Tacrolimus—atopic dermatitis	0.00224	0.00248	CcSEcCtD
Phenylpropanolamine—Hallucination—Prednisone—atopic dermatitis	0.00221	0.00244	CcSEcCtD
Phenylpropanolamine—Anxiety—Hydrocortisone—atopic dermatitis	0.0022	0.00243	CcSEcCtD
Phenylpropanolamine—Vomiting—Tacrolimus—atopic dermatitis	0.00216	0.00238	CcSEcCtD
Phenylpropanolamine—Rash—Tacrolimus—atopic dermatitis	0.00214	0.00236	CcSEcCtD
Phenylpropanolamine—Dermatitis—Tacrolimus—atopic dermatitis	0.00214	0.00236	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisolone—atopic dermatitis	0.00211	0.00234	CcSEcCtD
Phenylpropanolamine—Anxiety—Methylprednisolone—atopic dermatitis	0.00207	0.00228	CcSEcCtD
Phenylpropanolamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.00207	0.00228	CcSEcCtD
Phenylpropanolamine—Flushing—Prednisone—atopic dermatitis	0.00206	0.00227	CcSEcCtD
Phenylpropanolamine—Nausea—Tacrolimus—atopic dermatitis	0.00202	0.00223	CcSEcCtD
Phenylpropanolamine—Confusional state—Methylprednisolone—atopic dermatitis	0.002	0.00221	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisone—atopic dermatitis	0.00198	0.00219	CcSEcCtD
Phenylpropanolamine—Hypotension—Hydrocortisone—atopic dermatitis	0.00198	0.00218	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisolone—atopic dermatitis	0.00196	0.00216	CcSEcCtD
Phenylpropanolamine—Tachycardia—Triamcinolone—atopic dermatitis	0.00194	0.00215	CcSEcCtD
Phenylpropanolamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.00194	0.00214	CcSEcCtD
Phenylpropanolamine—Insomnia—Hydrocortisone—atopic dermatitis	0.00191	0.00211	CcSEcCtD
Phenylpropanolamine—Anxiety—Dexamethasone—atopic dermatitis	0.00188	0.00208	CcSEcCtD
Phenylpropanolamine—Anxiety—Betamethasone—atopic dermatitis	0.00188	0.00208	CcSEcCtD
Phenylpropanolamine—Hypotension—Methylprednisolone—atopic dermatitis	0.00186	0.00205	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisone—atopic dermatitis	0.00182	0.00201	CcSEcCtD
Phenylpropanolamine—Insomnia—Triamcinolone—atopic dermatitis	0.0018	0.00199	CcSEcCtD
Phenylpropanolamine—Insomnia—Methylprednisolone—atopic dermatitis	0.0018	0.00199	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisolone—atopic dermatitis	0.00179	0.00197	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Triamcinolone—atopic dermatitis	0.00178	0.00196	CcSEcCtD
Phenylpropanolamine—Agitation—Prednisone—atopic dermatitis	0.00177	0.00196	CcSEcCtD
Phenylpropanolamine—Tachycardia—Dexamethasone—atopic dermatitis	0.00176	0.00195	CcSEcCtD
Phenylpropanolamine—Tachycardia—Betamethasone—atopic dermatitis	0.00176	0.00195	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.00174	0.00193	CcSEcCtD
Phenylpropanolamine—Hypotension—Dexamethasone—atopic dermatitis	0.00169	0.00187	CcSEcCtD
Phenylpropanolamine—Hypotension—Betamethasone—atopic dermatitis	0.00169	0.00187	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00164	0.00181	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.00164	0.00181	CcSEcCtD
Phenylpropanolamine—Anxiety—Prednisone—atopic dermatitis	0.00164	0.00181	CcSEcCtD
Phenylpropanolamine—Insomnia—Dexamethasone—atopic dermatitis	0.00164	0.00181	CcSEcCtD
Phenylpropanolamine—Insomnia—Betamethasone—atopic dermatitis	0.00164	0.00181	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisolone—atopic dermatitis	0.0016	0.00176	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.00156	0.00172	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisone—atopic dermatitis	0.00154	0.0017	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Betamethasone—atopic dermatitis	0.00149	0.00165	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.00149	0.00165	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00147	0.00162	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00146	0.00162	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisolone—atopic dermatitis	0.00143	0.00158	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisone—atopic dermatitis	0.00142	0.00157	CcSEcCtD
Phenylpropanolamine—Dizziness—Hydrocortisone—atopic dermatitis	0.0014	0.00155	CcSEcCtD
Phenylpropanolamine—Rash—Prednisolone—atopic dermatitis	0.00137	0.00151	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisolone—atopic dermatitis	0.00136	0.00151	CcSEcCtD
Phenylpropanolamine—Constipation—Prednisone—atopic dermatitis	0.00135	0.00149	CcSEcCtD
Phenylpropanolamine—Vomiting—Hydrocortisone—atopic dermatitis	0.00135	0.00149	CcSEcCtD
Phenylpropanolamine—Rash—Hydrocortisone—atopic dermatitis	0.00133	0.00147	CcSEcCtD
Phenylpropanolamine—Dermatitis—Hydrocortisone—atopic dermatitis	0.00133	0.00147	CcSEcCtD
Phenylpropanolamine—Dizziness—Triamcinolone—atopic dermatitis	0.00132	0.00146	CcSEcCtD
Phenylpropanolamine—Dizziness—Methylprednisolone—atopic dermatitis	0.00131	0.00145	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisone—atopic dermatitis	0.0013	0.00143	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisolone—atopic dermatitis	0.00129	0.00142	CcSEcCtD
Phenylpropanolamine—Vomiting—Triamcinolone—atopic dermatitis	0.00127	0.0014	CcSEcCtD
Phenylpropanolamine—Vomiting—Methylprednisolone—atopic dermatitis	0.00126	0.0014	CcSEcCtD
Phenylpropanolamine—Nausea—Hydrocortisone—atopic dermatitis	0.00126	0.00139	CcSEcCtD
Phenylpropanolamine—Rash—Triamcinolone—atopic dermatitis	0.00126	0.00139	CcSEcCtD
Phenylpropanolamine—Dermatitis—Triamcinolone—atopic dermatitis	0.00126	0.00139	CcSEcCtD
Phenylpropanolamine—Rash—Methylprednisolone—atopic dermatitis	0.00125	0.00138	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methylprednisolone—atopic dermatitis	0.00125	0.00138	CcSEcCtD
Phenylpropanolamine—Dizziness—Betamethasone—atopic dermatitis	0.0012	0.00132	CcSEcCtD
Phenylpropanolamine—Dizziness—Dexamethasone—atopic dermatitis	0.0012	0.00132	CcSEcCtD
Phenylpropanolamine—Nausea—Triamcinolone—atopic dermatitis	0.00118	0.00131	CcSEcCtD
Phenylpropanolamine—Nausea—Methylprednisolone—atopic dermatitis	0.00118	0.0013	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisone—atopic dermatitis	0.00116	0.00128	CcSEcCtD
Phenylpropanolamine—Vomiting—Dexamethasone—atopic dermatitis	0.00115	0.00127	CcSEcCtD
Phenylpropanolamine—Vomiting—Betamethasone—atopic dermatitis	0.00115	0.00127	CcSEcCtD
Phenylpropanolamine—Rash—Dexamethasone—atopic dermatitis	0.00114	0.00126	CcSEcCtD
Phenylpropanolamine—Rash—Betamethasone—atopic dermatitis	0.00114	0.00126	CcSEcCtD
Phenylpropanolamine—Dermatitis—Dexamethasone—atopic dermatitis	0.00114	0.00126	CcSEcCtD
Phenylpropanolamine—Dermatitis—Betamethasone—atopic dermatitis	0.00114	0.00126	CcSEcCtD
Phenylpropanolamine—Nausea—Dexamethasone—atopic dermatitis	0.00107	0.00119	CcSEcCtD
Phenylpropanolamine—Nausea—Betamethasone—atopic dermatitis	0.00107	0.00119	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisone—atopic dermatitis	0.00104	0.00115	CcSEcCtD
Phenylpropanolamine—Vomiting—Prednisone—atopic dermatitis	0.001	0.00111	CcSEcCtD
Phenylpropanolamine—Rash—Prednisone—atopic dermatitis	0.000993	0.0011	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisone—atopic dermatitis	0.000992	0.0011	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisone—atopic dermatitis	0.000935	0.00103	CcSEcCtD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000129	0.00175	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	0.000127	0.00173	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000126	0.00172	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCL10—atopic dermatitis	0.000126	0.00172	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000126	0.00172	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000125	0.0017	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	0.000125	0.0017	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000124	0.00168	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000124	0.00168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—IL5—atopic dermatitis	0.000123	0.00167	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000122	0.00166	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000121	0.00165	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	0.000121	0.00165	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000121	0.00164	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000119	0.00163	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	0.000118	0.00161	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCL10—atopic dermatitis	0.000117	0.0016	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.000115	0.00157	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	0.000114	0.00155	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	0.000113	0.00154	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000113	0.00154	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL11—atopic dermatitis	0.000112	0.00153	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000112	0.00153	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000112	0.00153	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	0.000111	0.00151	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000111	0.00151	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	0.000111	0.00151	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FCER2—atopic dermatitis	0.000111	0.00151	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	0.000111	0.00151	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.00011	0.0015	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000109	0.00148	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000109	0.00148	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	0.000109	0.00148	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CCL5—atopic dermatitis	0.000109	0.00148	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000107	0.00145	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000107	0.00145	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000106	0.00144	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000106	0.00144	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL11—atopic dermatitis	0.000105	0.00142	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL5—atopic dermatitis	0.000104	0.00142	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	0.000103	0.00141	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL22—atopic dermatitis	0.000103	0.0014	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FCER2—atopic dermatitis	0.000103	0.0014	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	0.000102	0.00139	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	0.000101	0.00138	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	0.000101	0.00138	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	0.000101	0.00138	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000101	0.00138	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000101	0.00137	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	0.000101	0.00137	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	9.97e-05	0.00136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	9.91e-05	0.00135	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	9.88e-05	0.00135	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	9.88e-05	0.00135	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	9.81e-05	0.00134	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CCR5—atopic dermatitis	9.79e-05	0.00133	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GLB1—atopic dermatitis	9.74e-05	0.00133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	9.69e-05	0.00132	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.61e-05	0.00131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	9.58e-05	0.0013	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.4e-05	0.00128	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.39e-05	0.00128	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	9.39e-05	0.00128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	9.38e-05	0.00128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ADSL—atopic dermatitis	9.34e-05	0.00127	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	9.19e-05	0.00125	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	9.19e-05	0.00125	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	9.17e-05	0.00125	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CMA1—atopic dermatitis	9.14e-05	0.00124	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL11—atopic dermatitis	9.14e-05	0.00124	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	9.12e-05	0.00124	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	9.1e-05	0.00124	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	9.08e-05	0.00124	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	9.08e-05	0.00124	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	9e-05	0.00123	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	9e-05	0.00123	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL10—atopic dermatitis	8.91e-05	0.00121	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	8.88e-05	0.00121	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	8.83e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	8.82e-05	0.0012	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	8.63e-05	0.00117	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—STAT6—atopic dermatitis	8.59e-05	0.00117	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—IL6—atopic dermatitis	8.56e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	8.54e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	8.52e-05	0.00116	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CCL5—atopic dermatitis	8.44e-05	0.00115	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	8.37e-05	0.00114	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	8.36e-05	0.00114	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	8.36e-05	0.00114	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	8.24e-05	0.00112	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	8.21e-05	0.00112	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	8.21e-05	0.00112	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	8.2e-05	0.00112	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	8.17e-05	0.00111	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	8.17e-05	0.00111	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CXCL8—atopic dermatitis	8.14e-05	0.00111	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	8.03e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	8.03e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	8.02e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	8.01e-05	0.00109	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	7.83e-05	0.00107	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	7.77e-05	0.00106	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.77e-05	0.00106	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	7.72e-05	0.00105	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CCL5—atopic dermatitis	7.67e-05	0.00104	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	7.66e-05	0.00104	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CCR5—atopic dermatitis	7.61e-05	0.00104	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	7.6e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	7.59e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	7.59e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	7.59e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	7.55e-05	0.00103	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	7.45e-05	0.00101	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCR3—atopic dermatitis	7.45e-05	0.00101	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	7.43e-05	0.00101	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	7.35e-05	0.001	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	7.32e-05	0.000996	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.22e-05	0.000983	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	7.16e-05	0.000974	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	7.13e-05	0.000971	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	7.06e-05	0.000961	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CCR5—atopic dermatitis	6.91e-05	0.00094	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	6.89e-05	0.000938	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	6.84e-05	0.000931	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	6.83e-05	0.000929	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	6.74e-05	0.000918	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	6.7e-05	0.000911	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	6.69e-05	0.000911	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	6.65e-05	0.000905	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	6.65e-05	0.000905	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TAC1—atopic dermatitis	6.64e-05	0.000904	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NPS—atopic dermatitis	6.64e-05	0.000904	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	6.63e-05	0.000902	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	6.55e-05	0.000891	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCR3—atopic dermatitis	6.51e-05	0.000886	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	6.48e-05	0.000882	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	6.25e-05	0.00085	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	6.21e-05	0.000845	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	6.17e-05	0.00084	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	6.17e-05	0.00084	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL5—atopic dermatitis	6.17e-05	0.00084	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	6.14e-05	0.000836	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	6.07e-05	0.000827	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	6.02e-05	0.000819	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	5.97e-05	0.000812	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NPS—atopic dermatitis	5.97e-05	0.000812	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	5.92e-05	0.000806	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	5.9e-05	0.000803	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	5.85e-05	0.000797	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NPS—atopic dermatitis	5.84e-05	0.000795	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	5.84e-05	0.000795	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	5.81e-05	0.00079	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	5.72e-05	0.000779	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	5.71e-05	0.000777	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	5.58e-05	0.000759	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL5—atopic dermatitis	5.55e-05	0.000755	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	5.53e-05	0.000753	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	5.5e-05	0.000749	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL5—atopic dermatitis	5.43e-05	0.000739	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	5.42e-05	0.000737	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GLB1—atopic dermatitis	5.38e-05	0.000732	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	5.26e-05	0.000716	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	5.18e-05	0.000705	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADSL—atopic dermatitis	5.16e-05	0.000702	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	5.14e-05	0.0007	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	5.03e-05	0.000685	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	5.02e-05	0.000684	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	4.83e-05	0.000657	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	4.83e-05	0.000657	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	4.74e-05	0.000645	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PPARA—atopic dermatitis	4.73e-05	0.000644	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	4.73e-05	0.000644	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—IL2—atopic dermatitis	4.7e-05	0.00064	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	4.67e-05	0.000635	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	4.63e-05	0.00063	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.6e-05	0.000626	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL5—atopic dermatitis	4.53e-05	0.000617	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	4.49e-05	0.000611	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	4.49e-05	0.000611	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	4.49e-05	0.000611	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	4.4e-05	0.000599	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	4.39e-05	0.000598	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NGF—atopic dermatitis	4.19e-05	0.000571	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	4.18e-05	0.000568	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	4.17e-05	0.000568	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.13e-05	0.000563	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCR5—atopic dermatitis	4.08e-05	0.000555	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	4.07e-05	0.000554	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.04e-05	0.00055	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL2—atopic dermatitis	3.99e-05	0.000543	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	3.98e-05	0.000542	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	3.95e-05	0.000538	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.92e-05	0.000534	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	3.87e-05	0.000526	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	3.83e-05	0.000521	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NGF—atopic dermatitis	3.77e-05	0.000513	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	3.75e-05	0.000511	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NGF—atopic dermatitis	3.69e-05	0.000502	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	3.67e-05	0.0005	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	3.67e-05	0.000499	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	3.59e-05	0.000488	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	3.59e-05	0.000488	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	3.56e-05	0.000484	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	3.51e-05	0.000478	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	3.46e-05	0.000471	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.35e-05	0.000455	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	3.29e-05	0.000448	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	3.2e-05	0.000435	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPARA—atopic dermatitis	3.16e-05	0.00043	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	3.11e-05	0.000423	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.11e-05	0.000423	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	3.06e-05	0.000417	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	3.05e-05	0.000415	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	3.04e-05	0.000414	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	3.04e-05	0.000413	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	2.97e-05	0.000404	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	2.97e-05	0.000404	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	2.9e-05	0.000395	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	2.84e-05	0.000386	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.82e-05	0.000384	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	2.76e-05	0.000375	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	2.7e-05	0.000367	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.52e-05	0.000343	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	2.47e-05	0.000336	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL2—atopic dermatitis	2.36e-05	0.000321	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	2.35e-05	0.000319	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.34e-05	0.000318	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	2.22e-05	0.000302	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.17e-05	0.000295	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	2.17e-05	0.000295	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL2—atopic dermatitis	2.12e-05	0.000289	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	2.11e-05	0.000287	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL2—atopic dermatitis	2.07e-05	0.000282	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	2.06e-05	0.000281	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	1.95e-05	0.000266	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	1.91e-05	0.00026	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	1.79e-05	0.000244	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.75e-05	0.000238	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	1.71e-05	0.000233	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	1.71e-05	0.000232	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	1.67e-05	0.000227	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	1.59e-05	0.000217	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	1.59e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.58e-05	0.000215	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-05	0.0002	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—atopic dermatitis	1.39e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—atopic dermatitis	1.25e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—atopic dermatitis	1.22e-05	0.000166	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.01e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	9.37e-06	0.000127	CbGpPWpGaD
